Treatment of MC38 tumour bearing mice with anti-PD-1 antibody resulted in heterogeneous tumour responses, with delayed or reduced tumour growth, or both, in 4 out of the 5 mice (Fig. 5B) and shown for individual mice displayed in Supplementary Fig. 3. The gene discussed is PDCD1; the disease is neoplasm.